ITRATUF ORAL SOLUTION contains
Itraconazole
which belongs to a group of medicines called Antifungals. It is used to manage fungal infections in patients (with poor immune systems), which include yeast infections of the mouth, throat, or gullet. It is also used to manage fungal infections in patients with poor immunity systems that occur due to major blood disorders or bone marrow transplantation.
Yeast infection is a type of fungal infection that occurs when excess yeast (fungi) grows on the skin or other areas. It is generally characterized by symptoms such as white patches on the tongue, redness, soreness, or difficulty swallowing.
ITRATUF ORAL SOLUTION is not recommended for use in patients who are allergic to Itraconazole. Before taking ITRATUF ORAL SOLUTION, inform your doctor if you have heart problems (including congestive heart failure), kidney disorders, or liver problems (such as jaundice).
ITRATUF ORAL SOLUTION is not recommended for use in pregnant women unless it is clearly advised by the doctor, and it is not recommended for use in breast-feeding women. It is also not recommended for use in children and adolescents (aged below 18 years) or elderly patients unless it is clearly advised by the doctor.
The most common side effects of taking ITRATUF ORAL SOLUTION are headache, stomachache, nausea, vomiting, diarrhea, unpleasant taste, and rash. Consult your doctor if any of the side effects worsen.
No content available
